Item 8.01 Other Events. On April 27, 2020, Gene
Post# of 36537
(Total Views: 309)
Posted On: 06/19/2020 9:10:32 AM
Item 8.01 Other Events.
On April 27, 2020, Generex Biotechnology Corporation (“Generex”) received a letter of support from Corden Pharma Colorado, Inc. (CordenPharma), regarding Generex’s efforts to develop Generex’s li-Key-SARS-CoV-2 peptide vaccine with the goal to begin mass vaccination in the Fall of 2020. A copy of the letter of support is attached to this report as Exhibit 99.1 and is incorporated by reference herein.
About Corden Pharma Colorado, Inc.
Formed as the global pharmaceutical service & manufacturing platform of International Chemical Investors Group in 2006, CordenPharma is your full-service partner in the Contract Development & Manufacturing (CDMO) of APIs, Drug Products, and associated Packaging Services. Through a growing network of cGMP facilities across Europe and the US organized under five Technology Platforms – Peptides, Lipids & Carbohydrates - Highly Potent & Oncology - Injectables - Small Molecules - Antibiotics – CordenPharma experts translate complex processes, ideas and projects at any stage of development into high-value products.
On April 27, 2020, Generex Biotechnology Corporation (“Generex”) received a letter of support from Corden Pharma Colorado, Inc. (CordenPharma), regarding Generex’s efforts to develop Generex’s li-Key-SARS-CoV-2 peptide vaccine with the goal to begin mass vaccination in the Fall of 2020. A copy of the letter of support is attached to this report as Exhibit 99.1 and is incorporated by reference herein.
About Corden Pharma Colorado, Inc.
Formed as the global pharmaceutical service & manufacturing platform of International Chemical Investors Group in 2006, CordenPharma is your full-service partner in the Contract Development & Manufacturing (CDMO) of APIs, Drug Products, and associated Packaging Services. Through a growing network of cGMP facilities across Europe and the US organized under five Technology Platforms – Peptides, Lipids & Carbohydrates - Highly Potent & Oncology - Injectables - Small Molecules - Antibiotics – CordenPharma experts translate complex processes, ideas and projects at any stage of development into high-value products.
(2)
(0)Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Scroll down for more posts ▼